Trexquant Investment’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.1M | Buy |
304,067
+54,340
| +22% | +$3.78M | 0.14% | 160 |
|
|
2025
Q4 | $16.6M | Buy |
249,727
+180,635
| +261% | +$11.7M | 0.15% | 164 |
|
|
2025
Q3 | $4.65M | Buy |
+69,092
| New | +$5.47M | 0.05% | 576 |
|
|
2025
Q2 | – | Sell |
-120,891
| Closed | -$8.26M | – | 1607 |
|
|
2025
Q1 | $8.26M | Sell |
120,891
-105,129
| -47% | -$8.58M | 0.1% | 320 |
|
|
2024
Q4 | $17.6M | Sell |
226,020
-190,493
| -46% | -$14.1M | 0.2% | 117 |
|
|
2024
Q3 | $27.9M | Buy |
416,513
+229,044
| +122% | +$18.8M | 0.35% | 32 |
|
|
2024
Q2 | $21.3M | Buy |
187,469
+140,639
| +300% | +$17.8M | 0.32% | 36 |
|
|
2024
Q1 | $6.5M | Sell |
46,830
-140,008
| -75% | -$17.6M | 0.13% | 221 |
|
|
2023
Q4 | $23.2M | Sell |
186,838
-27,116
| -13% | -$2.77M | 0.52% | 18 |
|
|
2023
Q3 | $20M | Buy |
213,954
+112,795
| +112% | +$12.7M | 0.5% | 21 |
|
|
2023
Q2 | $13M | Buy |
101,159
+57,591
| +132% | +$6.97M | 0.34% | 50 |
|
|
2023
Q1 | $5.06M | Sell |
43,568
-88,621
| -67% | -$9.92M | 0.14% | 184 |
|
|
2022
Q4 | $15M | Buy |
132,189
+42,323
| +47% | +$4.65M | 0.42% | 37 |
|
|
2022
Q3 | $7.24M | Buy |
89,866
+72,150
| +407% | +$6.11M | 0.25% | 96 |
|
|
2022
Q2 | $1.32M | Buy |
+17,716
| New | +$1.62M | 0.06% | 403 |
|
|
2022
Q1 | – | Sell |
-47,004
| Closed | -$6.31M | – | 1439 |
|
|
2021
Q4 | $6.31M | Buy |
+47,004
| New | +$6.75M | 0.39% | 44 |
|
|
2021
Q2 | – | Sell |
-24,896
| Closed | -$2.24M | – | 1181 |
|
|
2021
Q1 | $2.24M | Buy |
+24,896
| New | +$2.34M | 0.21% | 126 |
|
|
2020
Q3 | – | Sell |
-41,928
| Closed | -$4.25M | – | 1268 |
|
|
2020
Q2 | $4.25M | Buy |
41,928
+26,056
| +164% | +$2.33M | 0.3% | 74 |
|
|
2020
Q1 | $1.07M | Buy |
+15,872
| New | +$988K | 0.08% | 402 |
|
|
2019
Q3 | – | Sell |
-92,040
| Closed | -$3.45M | – | 919 |
|
|
2019
Q2 | $3.45M | Sell |
92,040
-90,224
| -50% | -$2.84M | 0.31% | 99 |
|
|
2019
Q1 | $5.43M | Buy |
182,264
+94,720
| +108% | +$3.33M | 0.39% | 49 |
|
|
2018
Q4 | $2.62M | Sell |
87,544
-1,576
| -2% | -$50K | 0.16% | 180 |
|
|
2018
Q3 | $3.19M | Sell |
89,120
-140,620
| -61% | -$4.36M | 0.24% | 118 |
|
|
2018
Q2 | $5.46M | Buy |
+229,740
| New | +$4.87M | 0.38% | 55 |
|
|
2018
Q1 | – | Sell |
-167,492
| Closed | -$2.4M | – | 1141 |
|
|
2017
Q4 | $2.4M | Buy |
+167,492
| New | +$2.18M | 0.26% | 77 |
|
|
2017
Q3 | – | Sell |
-23,672
| Closed | -$433K | – | 836 |
|
|
2017
Q2 | $433K | Buy |
23,672
+12,264
| +108% | +$227K | 0.12% | 304 |
|
|
2017
Q1 | $242K | Sell |
11,408
-13,900
| -55% | -$271K | 0.03% | 878 |
|
|
2016
Q4 | $378K | Buy |
+25,308
| New | +$448K | 0.06% | 553 |
|
|
2016
Q1 | – | Sell |
-74,000
| Closed | -$1.51M | – | 971 |
|
|
2015
Q4 | $1.51M | Buy |
+74,000
| New | +$1.54M | 0.13% | 241 |
|
|
2015
Q2 | – | Sell |
-66,400
| Closed | -$1.03M | – | 1032 |
|
|
2015
Q1 | $1.03M | Buy |
+66,400
| New | +$1M | 0.11% | 347 |
|
Other funds holding DXCM
VCM
VPM
Trexquant Investment's DXCM Position: Q1 2026 in Review
Trexquant Investment increased its DexCom (DXCM) stake by 22% in Q1 2026, buying an estimated $3.78M and bringing the position to 304,067 shares worth $19.1M. The position accounts for 0.14% of the portfolio, ranked #160.
Trexquant Investment first reported a position in DXCM in Q1 2015 and has held it in 30 quarters since. The position peaked at $27.9M in Q3 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Trexquant Investment held 304,067 shares of DexCom worth $19.1M as of Q1 2026.
- Trexquant Investment bought 54,340 DexCom shares in Q1 2026, an estimated $3.78M.
- DexCom made up 0.14% of Trexquant Investment's portfolio in Q1 2026, its #160 holding.
- Trexquant Investment first reported a position in DexCom in Q1 2015 and has held it in 30 quarters since.
- Trexquant Investment's DexCom position peaked at $27.9M in Q3 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.